Sort
30,917 grants matching “tumor microenvironment”
Spatial omics technologies to map the senescent cell microenvironment
$557,900Nicola Neretti · Brown University · UG3 · FY2022 · CA
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$557,766Nikhil Joshi · Yale University · R01 · FY2020 · CA
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$557,766Nikhil Joshi · Yale University · R01 · FY2021 · CA
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$557,766Nikhil Joshi · Yale University · R01 · FY2022 · CA
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis
$557,736David B Agus · University Of Southern California · R01 · FY2014 · CA
Novel Methods of Chemo-sensitizing Low-proliferative Disseminated Tumor Cells in Triple Negative Breast Cancer
$557,734David D Tran · University Of Florida · R01 · FY2022 · CA
Immune Therapy for Brain Metastasis
$557,726Lucia Beatrice Jilaveanu · Yale University · R01 · FY2025 · CA
Development of novel protein-based therapeutics for lung cancer
$557,605Eric Alejandro Sweet-Cordero · University Of California, San Francisco · R01 · FY2019 · CA
Role of metalloproteinases in mammary gland remodeling
$557,582Zena Werb · University Of California, San Francisco · R01 · FY2009 · CA
Targeting SMARCA2 in SMARCA4-deficient lung cancers in vivo
$557,418Carla P Concepcion-Crisol · Columbia University Health Sciences · R37 · FY2025 · CA
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
$557,401Chi V. Dang · Johns Hopkins University · R01 · FY2025 · CA
Targeting Focal Adhesion Kinase to Improve RT-inducted Tumor Immunity
$557,274David G Denardo · Washington University · R01 · FY2022 · CA
Temporal analysis of the GBM tumor microenvironment during myeloid cell activating therapy
$557,266Ralph Weissleder · Massachusetts General Hospital · R01 · FY2024 · CA
The Impact of Obesity on Radiotherapy Anti-Tumor Effects
$557,116Arta Monir Monjazeb · University Of California At Davis · R01 · FY2023 · CA
Transmembrane Proteases and Prostate Carcinogenesis
$557,111Robert Vessella · University Of Washington · P01 · FY2012 · CA
CLINICAL THERAPY TRIALS
$557,066Katherine Kurshan Matthay · Children'S Hospital Of Los Angeles · P01 · FY2008 · CA
Abnormal Stem Cell Trafficking in IM
$557,056Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2015 · CA
Improving CAR-T efficacy against solid tumors by expanding lymph node reservoirs of âstem-likeâ CAR-T cells
$557,041Shivani Srivastava · Fred Hutchinson Cancer Center · R37 · FY2024 · CA
Immune Responses in Otitis Prone Children
$557,036Michael E Pichichero · Rochester General Hospital (Ny) · R01 · FY2014 · DC
Delineating Functional Immunity via Image-Guided PET
$556,992Nerissa Therese Viola · Wayne State University · R37 · FY2020 · CA
Defining Tumor Microenvironmental Mediators of Prostate Cancer Metastasis and Therapy Resistance
$556,981Paula Jill Hurley · Vanderbilt University Medical Center · R01 · FY2025 · CA
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial
$556,932Lei Zheng · Johns Hopkins University · R01 · FY2022 · CA
Stiffness-mediated genetic selection of cells
$556,865Shelly R. Peyton · Tufts University Medford · U01 · FY2025 · CA
Deciphering the role of p16INK4A+ fibroblasts in lung fibrosis
$556,850Tien Peng · University Of California, San Francisco · R01 · FY2025 · HL
Deciphering the role of p16INK4A+ fibroblasts in lung fibrosis
$556,850Tien Peng · University Of California, San Francisco · R01 · FY2022 · HL